NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 57 filers reported holding NABRIVA THERAPEUTICS PLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 6 | -100.0% | 0.00% | – |
| Q4 2019 | $49,000 | -44.9% | 37,008 | -17.3% | 0.00% | – |
| Q3 2019 | $89,000 | – | 44,726 | +171923.1% | 0.00% | – |
| Q2 2019 | $0 | – | 26 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 26 | -79.4% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 126 | -97.4% | 0.00% | – |
| Q3 2018 | $13,000 | -13.3% | 4,858 | +13.0% | 0.00% | – |
| Q2 2018 | $15,000 | -51.6% | 4,301 | -30.9% | 0.00% | – |
| Q1 2018 | $31,000 | -39.2% | 6,220 | -27.7% | 0.00% | – |
| Q4 2017 | $51,000 | – | 8,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,074,190 | $33,368,000 | 6.74% |
| Novo Holdings A/S | 2,903,800 | $23,782,000 | 3.10% |
| PURA VIDA INVESTMENTS, LLC | 425,000 | $3,481,000 | 1.02% |
| ACUTA CAPITAL PARTNERS, LLC | 400,000 | $3,276,000 | 0.59% |
| Monashee Investment Management LLC | 188,000 | $1,540,000 | 0.58% |
| Orbimed Advisors | 3,919,600 | $32,102,000 | 0.31% |
| FT Options LLC | 20,000 | $164,000 | 0.25% |
| Rock Springs Capital Management LP | 625,000 | $5,119,000 | 0.24% |
| Rubric Capital Management LP | 300,000 | $2,457,000 | 0.22% |
| Ghost Tree Capital, LLC | 120,000 | $983,000 | 0.21% |